| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.21 | 0.06 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.07 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.07 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.51 | 0.08 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.08 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.059 | 0.08 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.096 | 0.08 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.06 | 0.08 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.08 |